Ramy Sedhom, Medical Oncologist and
”This work needs more attention! Older adults are underrepresented in clinical trials and receive treatment with limited data on tolerability.
Mentee of Supriya Mohile shows primary dose reduction improves treatment tolerability among older adults with advanced cancer and age-related conditions.”
Read further.
Source: Ramy Sedhom/X